ADVENTRX Pharmaceuticals to Present at The Rodman & Renshaw Annual Global Investment Conference on September 14
SAN DIEGO, Sept. 1 /PRNewswire-FirstCall/ — ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today announced that the Company’s Chief Executive Officer, Brian M. Culley, will present at the Rodman & Renshaw Annual Global Investment Conference on Tuesday September 14, 2010 at 11:40 a.m. Eastern time, in the Hubbard Salon at the New York Palace Hotel in New York.
Interested parties can access a live audio webcast and slide presentation on the ADVENTRX Pharmaceuticals website at www.adventrx.com. An archived presentation will be available on the website for 30 days.
About ADVENTRX Pharmaceuticals
ADVENTRX Pharmaceuticals is a specialty pharmaceutical company whose product candidates are being developed to improve the performance of existing anti-cancer drugs by addressing limitations associated principally with their safety and use. More information can be found on the Company’s website at www.adventrx.com.
SOURCE ADVENTRX Pharmaceuticals, Inc.